Cargando…
ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity
SIMPLE SUMMARY: Due to improved survival upon effective anti-cancer therapies, the management of treatment-related side-effects is of increasing interest and importance. Cardiovascular side-effects of chemo-, targeted- and/or immunotherapies are common and can be harmful. To date, the identification...
Autores principales: | Pohl, Julia, Mincu, Raluca-Ileana, Mrotzek, Simone M., Wakili, Reza, Mahabadi, Amir A., Potthoff, Sophia K., Siveke, Jens T., Keller, Ulrich, Landmesser, Ulf, Rassaf, Tienush, Anker, Markus S., Totzeck, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999575/ https://www.ncbi.nlm.nih.gov/pubmed/33801913 http://dx.doi.org/10.3390/cancers13061197 |
Ejemplares similares
-
ECG Changes in Melanoma Patients Undergoing Cancer Therapy—Data from the ECoR Registry
por: Pohl, Julia, et al.
Publicado: (2020) -
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
por: Michel, Lars, et al.
Publicado: (2020) -
Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients
por: Mincu, Raluca Ileana, et al.
Publicado: (2019) -
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis
por: Mincu, Raluca I., et al.
Publicado: (2019) -
Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
por: Hinrichs, Lena, et al.
Publicado: (2020)